suPAR: the molecular crystal ball M Thunø, B Macho, J Eugen-Olsen Disease markers 27 (3-4), 157-172, 2009 | 633 | 2009 |
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021 | 449 | 2021 |
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble … K Kofoed, O Andersen, G Kronborg, M Tvede, J Petersen, J Eugen-Olsen, ... Critical care 11, 1-10, 2007 | 419 | 2007 |
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population J Eugen‐Olsen, O Andersen, A Linneberg, S Ladelund, TW Hansen, ... Journal of internal medicine 268 (3), 296-308, 2010 | 408 | 2010 |
Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data JPA Ioannidis, PS Rosenberg, JJ Goedert, LJ Ashton, TL Benfield, ... Annals of internal medicine 135 (9), 782-795, 2001 | 393 | 2001 |
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia J Helweg-Larsen, TL Benfield, J Eugen-Olsen, JD Lundgren, B Lundgren The Lancet 354 (9187), 1347-1351, 1999 | 317 | 1999 |
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals J Eugen-Olsen, AKN Iversen, P Garred, U Koppelhus, TL Benfield, ... Aids 11 (3), 305-310, 1997 | 277 | 1997 |
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection N Sidenius, CFM Sier, H Ullum, BK Pedersen, AC Lepri, F Blasi, ... Blood, The Journal of the American Society of Hematology 96 (13), 4091-4095, 2000 | 250 | 2000 |
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis M Ruhwald, T Bodmer, C Maier, M Jepsen, MB Haaland, J Eugen-Olsen, ... European respiratory journal 32 (6), 1607-1615, 2008 | 246 | 2008 |
Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses JM Gottwein, TKH Scheel, AM Hoegh, JB Lademann, J Eugen–Olsen, ... Gastroenterology 133 (5), 1614-1626, 2007 | 244 | 2007 |
Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis L Andresen, VL Jørgensen, A Perner, A Hansen, J Eugen-Olsen, ... Gut 54 (4), 503-509, 2005 | 238 | 2005 |
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization TKH Scheel, JM Gottwein, TB Jensen, JC Prentoe, AM Hoegh, HJ Alter, ... Proceedings of the National Academy of Sciences 105 (3), 997-1002, 2008 | 235 | 2008 |
The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau J Eugen-Olsen, P Gustafson, N Sidenius, K Fischer T, J Parner, P Aaby, ... The International Journal of Tuberculosis and Lung Disease 6 (8), 686-692, 2002 | 195 | 2002 |
The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality P Wittenhagen, G Kronborg, N Weis, H Nielsen, N Obel, SS Pedersen, ... Clinical Microbiology and Infection 10 (5), 409-415, 2004 | 192 | 2004 |
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia N Rovina, K Akinosoglou, J Eugen-Olsen, S Hayek, J Reiser, ... Critical Care 24, 1-3, 2020 | 189 | 2020 |
CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7. 7 M Ruhwald, M Bjerregaard-Andersen, P Rabna, K Kofoed, J Eugen-Olsen, ... Microbes and infection 9 (7), 806-812, 2007 | 166 | 2007 |
An open label trial of anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... Elife 10, e66125, 2021 | 160 | 2021 |
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score S Lyngbæk, JL Marott, T Sehestedt, TW Hansen, MH Olsen, O Andersen, ... International journal of cardiology 167 (6), 2904-2911, 2013 | 160 | 2013 |
Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor SJ Paulsen, MM Rosenkilde, J Eugen-Olsen, TN Kledal Journal of virology 79 (1), 536-546, 2005 | 156 | 2005 |
Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology K Kofoed, UV Schneider, T Scheel, O Andersen, J Eugen-Olsen Clinical chemistry 52 (7), 1284-1293, 2006 | 149 | 2006 |